HCA Healthcare Inc stock (US42225T1079): shares ease after recent gains as valuation comes into focus

HCA Healthcare Inc shares on the NYSE traded slightly lower after the latest session, with investors reassessing valuation metrics following a strong run since its first-quarter 2026 earnings update.

HCA Healthcare Inc shares on the New York Stock Exchange traded around the high 380s in USD in the latest session, modestly below recent highs after a strong run that followed the company’s first-quarter 2026 earnings release, according to recent trading data as of 05/28/2026 from MarketBeat and other price services.

The stock, which is part of the U.S. healthcare sector and included in major U.S. equity benchmarks, has seen active trading on the NYSE under the ticker HCA, with investors digesting both operating trends and updated valuation metrics after management reported its latest quarterly figures in April 2026, as reflected in the company’s April 2026 earnings materials.

The share price movement keeps the focus on the United States as HCA’s home market, where the company operates a large network of hospitals and related facilities and where its primary listing and liquidity are concentrated, while secondary trading in Europe, including Germany via venues such as Tradegate or Frankfurt, continues to play only a supplementary role for cross-border investors following the U.S.-dollar price.

For context on the latest closing level, MarketBeat data show HCA Healthcare closing at about USD 384.01 on 05/28/2026, with after-hours indications a fraction lower on that date, underlining a small decline on the day rather than a sharp move, while the stock remains significantly above levels seen a few years ago, supported by consistent earnings and cash generation over multiple reporting periods.

The stock traded at approximately 384 USD on 05/28/2026 on the New York Stock Exchange, according to MarketBeat as of 05/28/2026, illustrating that the current consolidation phase comes after a period in which analysts had highlighted improved fundamentals and an expanding hospital portfolio across key U.S. regions.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: HCA Healthcare Inc
• Sector/industry: Healthcare - hospitals and medical facilities
• Headquarters/country: Nashville, United States
• Core markets: United States hospital and outpatient care markets
• Key revenue drivers: Acute care hospital services, outpatient and ambulatory services, and related healthcare operations in U.S. metropolitan areas
• Home exchange/listing venue: New York Stock Exchange (HCA)
• Trading currency: USD

HCA Healthcare Inc: core business model

HCA Healthcare Inc runs a large-scale network of hospitals, outpatient centers, and related healthcare facilities in the United States, with revenue largely generated by inpatient and outpatient services reimbursed by private insurers, government programs, and self-pay patients.

Valuation metrics and multiples for HCA Healthcare Inc

With Friday’s module focused on valuation, investors are looking closely at core multiples such as the price-to-earnings ratio and enterprise value to EBITDA to gauge how HCA Healthcare is currently priced versus its earnings power and cash flow profile. Based on recent price levels near USD 384 and consensus forecasts compiled by services like MarketBeat as of 05/28/2026, the stock trades at a forward earnings multiple that reflects both the company’s scale and its exposure to U.S. hospital reimbursement dynamics, while remaining within the valuation range of larger U.S. managed care and provider peers.

According to MarketBeat as of 05/28/2026, 24 Wall Street analysts covering HCA Healthcare have issued twelve-month price targets that average around USD 515.77, implying upside from the late-May 2026 share price and providing an external reference point for how the market currently values the company’s earnings prospects and capital allocation strategy, including ongoing investments in facilities and workforce.

Conclusion

The latest trading session left HCA Healthcare shares slightly below recent highs, as investors balanced strong U.S.-based hospital operations against a valuation that already prices in continued earnings delivery. With the stock changing hands around USD 384 on the NYSE on 05/28/2026, the focus has shifted to how current earnings multiples and enterprise value metrics compare with both historical levels and the broader U.S. healthcare sector.

Consensus price targets compiled by third-party services point to potential upside from current levels, but the range of analyst expectations also highlights the sensitivity of valuation to reimbursement trends, cost inflation, and capital deployment decisions within the U.S. hospital market over the coming quarters.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.